APA (7th ed.) Citation

Grosskopf, A., Rahn, J., Kim, A., Szabó, G., Klawonn, F., Frolov, A., & Simm, A. (2024). Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease: A feasibility study. Biomedicines, 12(9), . https://doi.org/10.3390/biomedicines12092127

Chicago Style (17th ed.) Citation

Grosskopf, Anne, Jette Rahn, Ahyoung Kim, Gábor Szabó, Frank Klawonn, Andrej Frolov, and Andreas Simm. "Peptide-bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease: A Feasibility Study." Biomedicines 12, no. 9 (2024). https://doi.org/10.3390/biomedicines12092127.

MLA (9th ed.) Citation

Grosskopf, Anne, et al. "Peptide-bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease: A Feasibility Study." Biomedicines, vol. 12, no. 9, 2024, https://doi.org/10.3390/biomedicines12092127.